Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer

• Main Authors: Marianne J. Rutten (Author), Gabe S. Sonke (Author), Anneke M. Westermann (Author), Willemien J. van Driel (Author), Johannes W. Trum (Author), Gemma G. Kenter (Author), Marrije R. Buist (Author)
• Format: Book
• Published: Hindawi Limited, 2015-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Although complete debulking surgery for epithelial ovarian cancer (EOC) is more often achieved with interval debulking surgery (IDS) following neoadjuvant chemotherapy (NACT), randomized evidence shows no long-term survival benefit compared to complete primary debulking surgery (PDS). We performed a...